2 assets in Mucopolysaccharidosis Type 3B

Therapeutic assets addressing Mucopolysaccharidosis Type 3B, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ax 250 Mucopolysaccharidosis Type 3B	Allievex Corporation	P4	NR ()
Tralesinidase Alfa Mucopolysaccharidosis Type 3B	Spruce Biosciences	P3	NR ()